Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524742 | NSE Symbol : CAPLIPOINT | ISIN : INE475E01026 | Industry : Pharmaceuticals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
30-Oct-2024	07-Nov-2024	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2024 inter alia to consider and approve Un-audited Financial Results of the Company for the quarter and half-year ended September 30 2024 (both standalone and consolidated) Financial Results for the quarter and half-year ended September 30, 2024 is enclosed (As Per BSE Announcement Dated on 07.11.2024)
31-Jul-2024	07-Aug-2024	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Quarterly unaudited financials results Recommendation of Final Dividend Convening AGM and Fixing record date The Board has recommended Final Dividend of INR 2.5 per equity shares subject to the approval of shareholders (As Per BSE Announcement Dated on 07.08.2024)
09-May-2024	16-May-2024	Accounts	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve Annual audited financial results of the Company for the year ended March 31 2024 (both standalone & consolidated) and declaration of Interim Dividend if any for the FY 2023-24 and fixation of record date for determining the eligibility of shareholders. The Board had approved interim dividend for the year ended 31-03-2024. The details of the same is enclosed herewith (As Per BSE Announcement Dated on 16/05/2024)
30-Jan-2024	09-Feb-2024	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the un-audited financial results of the Company for the quarter and nine months ended December 31 2023 (both standalone & consolidated) Financial Results along with the Limited Review Report, Press Release and Investor PPT for the quarter ended December 31, 2023 is enclosed (As Per BSE Announcement dated on 09.02.2024)
01-Nov-2023	09-Nov-2023	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the un-audited financial results of the Company for the quarter and half-year ended September 30 2023 (both standalone & consolidated) Financial Results for QE 30-09-2023 along with press release and investor presentation is attached (As per BSE Announcement Dated on 09/11/2023)
31-Jul-2023	07-Aug-2023	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve 1) Quarterly unaudited financial results for the quarter ended June 30 2023 (both standalone & consolidated); 2) Recommendation of Final Dividend for the FY 2022-23 for approval of shareholders; 3) Convening the Annual General Meeting of the Company; and 4) Fixation of record date for determining the eligibility of shareholders entitled for the Final Dividend. Board approved: 1. Recommended a Final Dividend of INR. 2.5 (125%) per equity share of Rs.2 each for the financial year ended March 31, 2023. This shall be subject to approval of the shareholders at the forthcoming Annual General Meeting. 2. Recommended the appointment of M/s. Brahmayya & Co. Chartered Accountants, (Firm Registration No. 000511S) as the Statutory Auditors for a term of five years i.e., from the conclusion of the forthcoming 32nd Annual General Meeting until the conclusion of 37th Annual General Meeting to be held in the year 2028. (As Per BSE Bulletin Dated on 07.08.2023) Results for the quarter ended June 30, 2023 (As Per BSE Announcement Dated on 07.08.2023) Intimation under Regulation 30 of SEBI Regulations 2015 - Appointment of Statutory Auditors of the Company. (As Per BSE Announcement Dated on 21/09/2023)
13-May-2023	27-May-2023	Accounts	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve 1. Considering and Approving Quarterly and yearly Audited Financial Results. 2. Declaration of Interim Dividend. The Board Meeting to be held on 24/05/2023 has been revised to 27/05/2023 The Board Meeting to be held on 24/05/2023 has been revised to 27/05/2023 (As per BSE Announcement Dated on 22/05/2023) we wish to inform you that the Board of Directors, at its meeting held today, has, inter-alia, approved the following: 1. Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023. 2. Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend. 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2023 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4). 4.Further the Nomination and Remuneration Committee of the Board of Directors of the Company, has allotted 12,000 equity shares of face value Rs. 2/- each, to the employees of the Company, upon exercise of stock options under Employee Stock Options Scheme(s) of the Company. (As Per BSE Announcement Dated on 27.05.2023)
28-Jan-2023	11-Feb-2023	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 inter alia to consider and approve The quarterly un-audited financial results of the Company for the quarter ended December 31 2022 (both standalone & consolidated) Further to our intimation dated January 28, 2023 we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2022. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3). Further to our intimation dated January 28, 2023 we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2022. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3). (As Per BSE Announcement Dated on 11.02.2023)
02-Nov-2022	12-Nov-2022	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Saturday November 12 2022 to consider and approve inter-alia the un-audited financial results of the Company for the quarter and half year ended September 30 2022 (both standalone & consolidated) Un-audited standalone and consolidated financial results for quarter and half-year ended September 30, 2022 (As Per BSE Announcement Dated 12.11.2022)
05-Sep-2022	05-Sep-2022	AGM	Outcome of Board Meeting Appointment of Dr R Nagendran and Mr S Deenadayalan as Independent Directors of the Company (As Per BSE Announcement dated on 30.09.2022)
28-Jul-2022	05-Aug-2022	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company wilt be held on Friday August 5 2022 to consider and approve inter-alia: i) the quarterly un-audited financial results of the Company for the quarter ended June 30 2022 (both standalone & consolidated) and ii) recommendation of Final Dividend for the FY 2021 - 22 and fixation of record date for determining the eligibility of shareholders. Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 05, 2022, inter alia, has recommended a Final Dividend of Rs. 2 (100%) per equity share of Rs. 2 each for the financial year ended March 31, 2022. This shall be subject to approval of the shareholders at the forthcoming Annual General Meeting. Outcome of Board Meeting Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 05, 2022, inter alia, has recommended a Final Dividend of Rs. 2 (100%) per equity share of Rs. 2 each for the financial year ended March 31, 2022. This shall be subject to approval of the shareholders at the forthcoming Annual General Meeting. (As Per BSE Announcement Dated on 05.08.2022)
05-May-2022	12-May-2022	Accounts	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 inter alia to consider and approve Board meeting intimation to consider and approve inter-alia: i) the annual audited financial results of the Company for the year ended 31st March 2022 (both standalone & consolidated) and ii) declaration of Interim Dividend if any for the FY 2021-22 and fixation of record date for determining the eligibility of shareholders. Declaration of Interim Dividend of Rs.2/- (100%) for the Financial Year 2021-22 (As Per BSE Announcement dated on 12.05.2022) Further to our letter dated May 12, 2022 on the outcome of the Board meeting, we enclose herewith the copy of newspaper advertisement with respect to financial results published today in the Financial Express (English Newspaper) and Maalai Malar (Tamil Newspaper). Kindly take the same on your records. (As Per BSE Announcement Dated on 13.05.2022)
28-Jan-2022	03-Feb-2022	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company will be held on Thursday February 3 2022 to consider and approve inter-alia the standalone and consolidated un-audited financial results of the Company for the quarter and nine months ended December 31 2021. This intimation is being given in compliance with the provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. As informed earlier vide our letter dated December 28 2021 the trading window for dealing in the Companys scrips by the Directors and Designated Employees of the Company will remain closed from January 1 2022 to February 5 2022 (both days inclusive) in terms of the Companys Code of Conduct to regulate monitor and report trading by insiders read with SEBI (Prohibition of Insider Trading) Regulations 2015. Further to our intimation dated January 28, 2022, we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2021. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3). The meeting commenced at 11:00 A.M and concluded at 12:45 P.M. Kindly take the same on your records. (As Per BSE Announcement dated on 03.02.2022)
27-Oct-2021	02-Nov-2021	Quarterly Results	Quarterly Results
30-Jul-2021	05-Aug-2021	Quarterly Results	CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve i) the quarterly un-audited financial results of the Company for the quarter ended 30th June 2021 (both standalone & consolidated) and ii) recommendation of Final Dividend, for the FY 2020-21 and fixation of record date for determining the eligibility of shareholders. Recommended a Final Dividend of Rs. 1.50/- (75 %) per equity share of Rs.2 each for the financial year ended 31st March 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting. Outcome of Board Meeting (As Per BSE Announcement Dated on 05.08.2021)

1 2

LOGIN HERE

Caplin Point Laboratories Ltd

Board Meeting